Evaluating the Treatment of Diabetic Macular Edema with Aflibercept Based on a Regional Network of Ophthalmologic Care Givers
Table 1
Age, sex, and baseline-values for BCDVA and CRT for the whole study population and for the subgroups who had their final visit at month 36 or before the month 36. The value describes the difference of the visual acuity and the central retinal thickness at the baseline and at the final visit between the two groups.
Total (n = 33)
Baseline value of group finishing at visit month 36 n = 27
Baseline value of group finishing before visit month 36 n = 27
